This expansion includes exclusive distribution agreements as well as new market authorisation transfers. The current agreement in Japan follows the last year agreement between the two companies for The post Essential and Clinigen expand JAPAC partnership to drive patient access appeared first on Pharmaceutical Business review.
Clinigen is an England-based pharmaceutical company that offers services such as clinical supplies management and critical medicine development for commercial markets.